TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
44 hedge funds and large institutions have $39M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $58.4M → $39M (-$19.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
44
Holding in Top 10
1
Calls
$439K
Puts
$204K
Top Buyers
| 1 | +$3.04M | |
| 2 | +$556K | |
| 3 | +$540K | |
| 4 |
Renaissance Technologies
New York
|
+$516K |
| 5 |
TI
Telemetry Investments
New York
|
+$350K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$366K | |
| 3 | -$205K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$134K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$113K |